Brand name: Darvon
Public Citizen has been assessing the quality and efficacy of drugs and devices since its founding in 1971. We use the law, petitions, and letters to monitor the FDA and coax the agency into action. Our actions have contributed to many drugs being pulled off the market. Public Citizen has also been instrumental in getting “black box” and other warnings on drugs. Our advocacy work on this drug is available below.
If you are interesting in reading our evaluations of the safety and efficacy of medications as well as information on drug side effects and interactions, please visit WorstPills.org.
More information on propoxyphene (Darvon)
- Position Statement: Delayed FDA Removal of Painkiller Propoxyphene (Darvon, Darvocet) From U.S. Market Has Cost More Than 1,000 U.S. Lives, November 19, 2010
- Chronology of Events Related to Propoxyphene (Darvon, Darvocet), November 19, 2010
- Letter to FDA Praising Food Safety Cautiousness, Attacking Drug Safety Recklessness, March 8, 2010
- Petition Asking FDA to Reconsider Banning Propoxyphene (Darvon), August 6, 2009
- Statement: FDA Committee Vote Confirms Propoxyphene’s (Darvon’s) Risks Outweigh Benefits, Drug Should Be Banned, January 30, 2009
- Testimony on Propoxyphene (Darvon), January 30, 2009
- Public Citizen v. FDA (Seeking order compelling FDA to respond to Public Citizen petition to ban Darvon), June 19, 2008
- Petition to Ban all Propoxyphene (Darvon) Products, February 28, 2006